Minor
Immunogenicty of Plonmarlimab · Acute Gouty Arthritis
Trial sites expanded: 1 → 30 locations
TJ Biopharma Co., Ltd.Phase 2 NCT07453004 Registry history of NCT07453004 on ClinicalTrials.gov (opens the registry)
Updated
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 1 → 30 locations
TJ Biopharma Co., Ltd.Phase 2 NCT07453004 Registry history of NCT07453004 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1 | 1 | |
| Phase 2 | 2 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07208058 | A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of… | Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis | Recruiting | 2026-10-15 |
| Phase 2/3 | ||||
| NCT06984588 | A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and… | Non Small Cell Lung Cancer | Active, Not Recruiting | 2026-01-30 |
| Phase 2 | ||||
| NCT07453004 | A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty… | Acute Gouty Arthritis | Recruiting | 2026-10-15 |
| NCT07005336 | A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus… | Non Small Cell Lung Cancer | Active, Not Recruiting | 2026-01-30 |
| Phase 1 | ||||
| NCT07715747 | A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of… | Solid Tumor | Not Yet Recruiting | 2026-07-20 |
Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Endometrial Cancer (1) · Gastric Cancer (1) · Ovarian Cancer (1)